Keywords: eyetech, sees, losses, grow, macugen, development, costs

Eyetech sees losses grow on Macugen development costs

Article | 02 August 2004

Eyetech Pharmaceuticals, a US biopharmaceutical company that specializesin the development and commercialization of novel therapeutics to treat diseases of the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Gilead Sciences

Giliad Sciences

Isis Pharmaceuticals

Pfizer

Go to company listing

Related Drugs

Macugen

Pegaptanib Sodium

Amino Acids

Injection

Physostigmine Salicylate

Go to drug listing